Table 1 Sample characteristics
Groups | |||
|---|---|---|---|
Variable | Hypertension (n=41) | Healthy (n=41) | P-value (between groups) |
Men, n (%) | 18 (44%) | 19 (46%) | 0.824a |
Age (years) | 48.9±11.6 | 32.8±6.2 | <0.001b |
Height (m) | 1.71±0.07 | 1.72±0.07 | 0.344b |
Weight (kg) | 83.2±15.2 | 76.2±9.1 | 0.007b |
Body mass index (kg m−2) | 28.2±4.2 | 25.7±2.0 | 0.001b |
Hypertension course (months) | 63.9±72.6 | 0±0 | NT |
Office blood pressure (mm Hg) | |||
Systolic | 156.4±17.7 | 130.0±6.0 | <0.001b |
Diastolic | 91.3±8.0 | 84.7±4.5 | <0.001b |
Mean arterial pressure | 113.0±10.0 | 99.8±4.5 | <0.001b |
Pulse pressure | 65.0±14.5 | 45.3±4.5 | <0.001b |
Risk factors, n (%) | |||
Quantity of risk factors | 0 (0; 2) | 2 (0; 5) | NT |
Smoker | 15 (37%) | 6 (15%) | 0.023a |
Sedentary | 26 (63%) | 8 (20%) | <0.001a |
History of premature CVD | 15 (37%) | 0 (0%) | NT |
Obesity | 11 (27%) | 1 (2%) | 0.002a |
Dyslipidemia | 35 (85%) | * | NT |
Diabetes mellitus | 10 (24%) | * | NT |
Physical activity level | |||
Very active | 2 (5%) | 10 (24%) | 0.001a |
Active | 12 (29%) | 23 (56%) | <0.001a |
Irregularly active A | 9 (22%) | 4 (10%) | 0.002a |
Irregularly active B | 18 (44%) | 4 (10%) | <0.001a |
Antihypertensive drug treatment, n (%) | |||
Quantity of medications | 3 (1; 5) | 0 (0; 0) | NT |
Diuretics | 40 (98%) | 0 (0%) | NT |
Vasodilator | 39 (95%) | 0 (0%) | NT |
β-Blocker | 18 (44%) | 0 (0%) | NT |
ACE inhibitors | 8 (20%) | 0 (0%) | NT |
Sympatholytic | 3 (7%) | 0 (0%) | NT |
AT2 antagonist | 1 (2%) | 0 (0%) | NT |
